The University of Hong Kong has pioneered a first-of-its-kind clinical trial that integrates lipofilling surgical practices with breast conservation, providing a new solution for cancer patients that promises to improve their well-being post-operation.
Advertisement
The preliminary findings released on Thursday by the university’s Li Ka Shing Faculty of Medicine also showed that breast cancer patients who underwent the procedure showed no signs of immediate surgical complications or recurrence of the disease.
“One of the biggest fears for many women diagnosed with breast cancer is the possibility of losing their breasts,” said Ava Kwong Hoi-wai, a clinical professor and breast cancer researcher who led the university’s study.
“Our goal is to expand the treatment options for patients suitable for breast-conserving surgery to improve post-operative breast symmetry and natural appearance – ultimately improving patients’ confidence and quality of life,” she said.
Breast cancer was the most common form of cancer among women in Hong Kong in 2022, according to the Centre for Health Protection. It was also the third leading cause of cancer-related deaths among women in 2023.
Advertisement
While a mastectomy, or breast removal surgery, has traditionally been the most common form of treatment for breast cancer, women are increasingly receiving a type of conserving surgery where parts of the surrounding tissue are used to reshape the breast after the tumour has been removed.